Study of HST101 for high cholesterol in Chinese patients
Treatments studied
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You weigh at least 40 kg (88 lbs) and your BMI is between 18 and 35.
- You have been on a stable dose of cholesterol-lowering pills (like statins) for at least 4 weeks.
- You have a history of heart disease, stroke, or are at high risk, and your LDL cholesterol is high enough and triglycerides are not too high.
- You do not have severe kidney disease, poorly controlled diabetes, or recent heart events.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, HST101, to see if it is safe for healthy Chinese people with high cholesterol. It is an early-phase trial, so it focuses on safety first.
This study tests a new injection called ART002g1 for people with an inherited form of high cholesterol (heterozygous familial hypercholesterolemia). The goal is to see if it is safe and can help lower cholesterol levels.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
This trial tests a new medicine, SHR-1918, for people whose bad cholesterol (LDL-C) stays high even when they take statins and another type of cholesterol-lowering drug called a PCSK9 inhibitor. It aims to see if this additional treatment can lower their cholesterol more effectively.
This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.
This study tests a new medication called SYH2053 to see if it helps lower 'bad' cholesterol more effectively when added to your current statin therapy. It is for patients whose cholesterol is still not at their doctor's target level, and it aims to improve heart health.
Hear when a new Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.